Huma Qamar
CIK: 0002015296
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OCGN
Ocugen, Inc.
Officer
Discretionary Trading P&L
Holdings
About Qamar Huma
Qamar Huma (SEC CIK 0002015296) files insider reports with the SEC as Chief Medical Officer of Ocugen, Inc. (OCGN).
Signal8 holds 1 ownership filing by Qamar Huma, a Form 4, filed on Jan 6, 2025. Those filings report 1 transaction, the latest on Jan 2, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Qamar Huma's filings is in MALVERN, PA.
Recent filings by Qamar Huma
- Jan 2, 2025: Grant or award of OCGN derivative securities (Form 4, code A).
Other insiders filing for Ocugen, Inc. (OCGN)
- Musunuri Shankar, Chief Executive Officer
- Johnson-Greene Treerita Essalima, Chief Financial Officer
- Kompella Uday, Director
- Chandrasekhar Satishchandran, Director
- Castillo Kirsten, Director
- Zhang Junge, Director